Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 44Breast Neoplasms 26Sarcoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Burkitt Lymphoma 14Neuroblastoma 13Hodgkin Disease 13Leukemia 12Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 8Wilms Tumor 7Sarcoma, Synovial 7Neurofibrosarcoma 7Leiomyosarcoma 7Histiocytoma, Malignant Fibrous 7Hemangiosarcoma 7Fibrosarcoma 7Endometrial Neoplasms 7Urinary Bladder Neoplasms 6Multiple Myeloma 6Malignant mesenchymal tumor 6Liposarcoma 6Rhabdomyosarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Kidney Neoplasms 5Hemangiopericytoma, Malignant 5Waldenstrom Macroglobulinemia 4Sarcoma, Alveolar Soft Part 4

Interventions

Taxes 2Specimen Handling 2Paclitaxel 2Docetaxel 2pembrolizumab 1Surgical Procedures, Operative 1Standard of Care 1Practice Guidelines as Topic 1Doxorubicin 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Anatomic Stage I Breast Cancer AJCC v8 × Doxorubicin × Clear all
NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

SWOG Cancer Research Network

Phase 3 Recruiting
2,400 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡